Latest Posts
About This Stock
More About This Stock
Read
Synthetic THC Researcher Mira Pharmaceuticals Debuts On Nasdaq
Article By:
The Fly
Sunday, August 6, 2023 12:19 PM EDT
Mira Pharmaceuticals made its public debut on the Nasdaq this week. The company raised $8.9 million in its IPO, which it intends to use towards accelerating toxicology and clinical research of its synthetic marijuana analog.